1-4 of 4
Uwe M. Martens, MD
Close
Sort by
Journal Articles

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Heuser, MD, Daniela Späth, MSc, Carina Morlok, Alexander Lamparter, Klaus-Henning Koehne, M.D., Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, Andrea Kündgen, M.D., Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R. Salih, MD, Katharina S. Goetze, MD, Gerald Wulf, MD, Matthias Theobald, MD, PhD, Mathias J. Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, MD, Uwe M. Martens, MD, Richard Greil, MD, Hartmut Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Sabine Kayser, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 3878.
https://doi.org/10.1182/blood.V122.21.3878.3878
Published: 2013
Journal Articles

Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3 -ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16-10 Trial

Sabine Kayser, MD, Mark Levis, MD, PhD, Carina Morlok, Andrea Kuendgen, MD, Michael Heuser, MD, Walter Fiedler, MD, Joerg Westermann, MD, Katharina Goetze, MD, Helmut R. Salih, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Heinz A. Horst, MD, Uwe M. Martens, MD, Gerald Wulf, MD, Michael Luebbert, MD, Ph.D., Dominik Wolf, MD, Richard Greil, MD, Claus-Henning Koehne, MD, Mark Ringhoffer, MD, Hartmut Kirchner, MD, Michael Pfreundschuh, MD, Brigitte Schlegelberger, MD, PhD, Patricia Erdmann, Trivikram Rajkhowa, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Arnold Ganser, Hartmut Doehner, MD, Konstanze Doehner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 1283.
https://doi.org/10.1182/blood.V122.21.1283.1283
Published: 2013
Journal Articles

Azacitidine-Containing Induction Regimens Followed by Azacitidine Maintenance Therapy in High Risk Acute Myeloid Leukemia: First Results of the Randomized Phase-II AMLSG 12-09 Study (ClinicalTrials.gov No. NCT01180322)

Richard F Schlenk, MD, Wolfgang Herr, MD, Gerald Wulf, Helmut R Salih, MD, Jürgen Krauter, Prof. Dr. med., Hans Guenter Derigs, MD, Andrea Kündgen, Mark Ringhoffer, MD, Uwe M. Martens, MD, Bernd Hertenstein, Martin Griesshammer, MD, PhD, Michael Girschikofsky, MD, Helga Bernhard, MD, Jens Kersten, MD, Maria von Lilienfeld-Toal, MD, Elisabeth Koller, MD, Elisabeth Lange, MD, Jörg Westermann, MD, Daniela Späth, MSc, Gudrun Göhring, MD, Veronica Teleanu, MD, Axel Benner, Dipl.Stat., Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 412.
https://doi.org/10.1182/blood.V120.21.412.412
Published: 2012
Journal Articles

Telomere Elongation In Vivo and Clinical Response Upon Androgen Treatment in a Patient with Aplastic Anemia and a Heterozygous hTERT Gene Mutation,

Tim H Brümmendorf, Patrick Ziegler, PhD, Jamil Akkad, MD, Ute Brassat, PhD, Lucia Vankann, Jens Panse, MD, Stefan Wilop, MD, Stefan Balabanov, MD, PhD, Klaus Schwarz, MD, Uwe M. Martens, MD, PhD, Hubert Schrezenmeier, MD
Journal: Blood
Blood (2011) 118 (21): 3427.
https://doi.org/10.1182/blood.V118.21.3427.3427
Published: 2011